🇺🇸 FDA
Pipeline program

Neratinib

MCC-17-13821

Phase 2 small_molecule active

Quick answer

Neratinib for Solid Tumor, Adult is a Phase 2 program (small_molecule) at PUMA BIOTECHNOLOGY, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
PUMA BIOTECHNOLOGY, INC.
Indication
Solid Tumor, Adult
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials